Cochlear Receives FDA Clearance for Osia 3 Sound Processor
Cochlear's newest active bone conduction sound processor features a fully rechargeable battery, expanded fitting range, a new signal processing chip, and multi-platform wireless streaming.
Cochlear's newest active bone conduction sound processor features a fully rechargeable battery, expanded fitting range, a new signal processing chip, and multi-platform wireless streaming.
Are you and your staff prepared for unexpected health events at work?
nnoCaption is announcing a planned leadership transition to guide its next phase of growth.
Evaxion's EVX-V1 vaccine candidate uses an AI-driven, multi-antigen approach to target cytomegalovirus — a leading cause of congenital hearing loss.
From building rapport to leveraging technology, HCPs share creative strategies to keep kids engaged for successful pediatric testing.
Hearing practices often lose prospective patients not because of a lack of leads, but because inconsistent and unstructured follow-up processes allow interested patients to disengage before receiving care.